PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver cirrhosis |
| Symptom | C0085584|encephalopathy |
| Sentences | 38 |
| PubMedID- 26057656 | Clinical parameters included hepatic encephalopathy (he), history of alcohol abuse, liver cirrhosis (lc) and ascites. |
| PubMedID- 21757988 | Metronidazole-induced encephalopathy in a patient with liver cirrhosis. |
| PubMedID- 19903725 | Standardized nomenclature has been proposed but a standardized approach to the treatment, particularly of persistent, episodic and recurrent encephalopathy associated with liver cirrhosis has not been proposed. |
| PubMedID- 25867912 | Objective: to determine the efficacy of rifaximin once a day dose in the prevention of hepatic encephalopathy (he) in patients with liver cirrhosis as compared with twice daily dose of rifaximin. |
| PubMedID- 21978390 | Systemic translocation of gut-derived bacteria and their products is a risk factor for recurrent spontaneous bacterial peritonitis and/or encephalopathy in patients with liver cirrhosis . |
| PubMedID- 25420740 | However, it is often very difficult to differentiate between cryptococcal meningitis and hepatic encephalopathy in patients with liver cirrhosis, and there is delay in making the diagnosis. |
| PubMedID- 20216550 | Increased blood-brain barrier (bbb) permeability for ammonia is considered to be an integral part of the pathophysiology of hepatic encephalopathy (he) in patients with liver cirrhosis. |
| PubMedID- 22646055 | Relationship between interleukin-6 and ammonia in patients with minimal hepatic encephalopathy due to liver cirrhosis. |
| PubMedID- 24709242 | Objective: to determine the efficacy of rifaximin in prevention of repeated episodes of hepatic encephalopathy in patients with liver cirrhosis as compared to placebo. |
| PubMedID- 25847088 | Aim: to examine whether the brain exhibits metabolic disorder prior to overt hepatic encephalopathy in patients with liver cirrhosis (lc), the intracerebral glutamine and myo-inositol levels were determined using 3.0-tesla (t)1 h (proton) magnetic resonance spectroscopy (mrs). |
| PubMedID- 22734925 | Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: occlusion of portosystemic shunt in combination with splenectomy. |
| PubMedID- 23626595 | Even if a patient has liver cirrhosis with hepatic encephalopathy, liver cirrhosis should not be considered to be the only cause of hyperammonemia. |
| PubMedID- 20934771 | Conclusions: sedation with propofol has a shorter time recovery and a shorter time to discharge than midazolam and does not exacerbate sub-clinical hepatic encephalopathy in patients with compensated liver cirrhosis. |
| PubMedID- 25060166 | Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted mr imaging and proton mr spectroscopy of the brain. |
| PubMedID- 25674427 | Supplementation with bcaas normalizes amino acid profiles, ameliorates complications such as encephalopathy and hypoalbuminemia in patients with liver cirrhosis (kawaguchi et al. |
| PubMedID- 25509200 | The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 23225825 | Previously studies have investigated the effect of propofol on sub-clinical hepatic encephalopathy in patients with compensated liver cirrhosis.11,18 these studies found that propofol sedation during upper gastrointestinal endoscopy did not cause acute deterioration of sub-clinical hepatic encephalopathy.11,18 however, in patients with liver cirrhosis, hepatic function reserve is quite limited, and a cirrhotic liver is less tolerant to hemodynamic changes and surgical stress.1 therefore, anesthetic agents should be titrated with caution in cirrhotic patients to minimize the adverse effects of drugs and to stabilize hemodymanics. |
| PubMedID- 25100119 | Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials. |
| PubMedID- 24078984 | Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 23967390 | Furthermore, it is used for prophylaxis of hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 20506574 | Wernicke encephalopathy following splenectomy in a patient with liver cirrhosis: a case report and review of the literature. |
| PubMedID- 20852922 | The mean cff was higher in patients after liver transplantation, but did not reach statistical significance.table 2surrogate markers for hepatic encephalopathy in patients with liver cirrhosis and those who have received liver transplants. |
| PubMedID- 26516441 | In our study, hyponatremia was associated with increased incidence of hepatic encephalopathy in patients with decompensated liver cirrhosis. |
| PubMedID- 23414576 | In pharmacological therapy, ornithine is used to decrease blood ammonia concentrations and reduce the symptoms of hepatic encephalopathy associated with liver cirrhosis6. |
| PubMedID- 22870180 | Here we report on a patient suffered from liver cirrhosis with recurrent hepatic encephalopathy who developed mnz-induced neurotoxicity. |
| PubMedID- 26265724 | Hepatic encephalopathy due to liver cirrhosis. |
| PubMedID- 25068951 | Among the 130 patients who survived ≥90 days after admission, 66 (51%) were complicated by liver cirrhosis, including 22 with encephalopathy, and 21 with ascites. |
| PubMedID- 20010298 | Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 21483460 | 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 25459346 | Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes. |
| PubMedID- 25420513 | Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension. |
| PubMedID- 20482828 | Severe hepatic encephalopathy in a patient with liver cirrhosis after administration of angiotensin-converting enzyme inhibitor/angiotensin ii receptor blocker combination therapy: a case report. |
| PubMedID- 20642112 | Low doses are used as a food supplement and high doses (above 5 g) as a medicinal product to lower blood ammonia concentration and to eliminate symptoms of hepatic encephalopathy associated with liver cirrhosis. |
| PubMedID- 22384773 | Minimal hepatic encephalopathy in patients with decompensated liver cirrhosis. |
| PubMedID- 25932262 | Aim: to determine the effects of small-intestinal bacterial overgrowth (sibo) and rifaximin therapy on minimal hepatic encephalopathy (mhe) with liver cirrhosis. |
| PubMedID- 21416318 | Pylori) bacteria convert urea to ammonia, which has been implicated in causation of hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 23742732 | Prospective randomized clinical trials that compared the effects of zinc supplementation with those of no intervention, placebo, or standard therapy on hepatic encephalopathy in patients with liver cirrhosis were included. |
| PubMedID- 24974838 | Infection and liver cirrhosis: possible association with hepatic encephalopathy and/or post-hepatic encephalopathy cognitive impairment in patients with portal hypertension. |
Page: 1